# Alcohol on a GLP-1: what changes and why Updated 24 August 2026 · Written by the Penwise team One of the most consistently reported effects of these drugs is not on the scale at all. People describe wanting to drink less, forgetting to finish a glass, and finding that the second drink simply does not appeal. It happens often enough that it is now being studied deliberately. Alongside that, there are a few practical things about drinking on a slowed stomach that are worth knowing before the first night out. ## Why the desire to drink drops The appetite effects of GLP-1 drugs are not purely a stomach phenomenon. GLP-1 receptors are present in brain regions involved in reward and motivation, which is the same reasoning that explains [food noise](https://penwiseapp.com/en/guides/what-is-food-noise) going quiet. Alcohol runs through overlapping circuitry, and a large number of people on treatment report the craving for it fading in the same way the craving for snacks did. This moved from anecdote to research quickly. Observational data and early clinical trials have examined GLP-1 drugs specifically for alcohol use disorder, with encouraging enough signals that larger studies are running. None of that makes these drugs an approved treatment for drinking, and nobody should be prescribed one for that reason outside a trial. It does mean the effect people describe is real and has a plausible mechanism, rather than being coincidence. > For some people this is one of the most valued effects of treatment. For others it is a loss, because a glass of wine with dinner stopped being enjoyable. Both are normal reactions and worth mentioning at a review if the change is unwelcome. ## How alcohol hits differently on a slowed stomach This is the practical part, and it surprises people who have been drinking the same way for twenty years. - **The timing shifts.** Alcohol is absorbed mainly in the small intestine, so anything that changes how fast the stomach empties changes when it arrives. On these drugs the arrival can be later, slower, and less predictable than you are used to. - **A tolerance you know may not apply.** Many people report becoming affected by noticeably less than before. Whether that is the changed absorption, a much smaller food intake alongside it, or simply less body mass, the practical answer is the same: find out carefully rather than assume. - **Nausea stacks.** Alcohol irritates the stomach lining on its own. Doing it on a stomach that is already emptying slowly, in the two or three days after a shot when the drug level peaks, is how a modest evening becomes a bad night. - **Drinking on an almost empty stomach is now more likely.** Skipping dinner because you were not hungry, then drinking, is a common pattern on these drugs and a reliably bad one. ## Where real caution is warranted None of the product labels prohibit alcohol, and this page is not a licence either. There are specific situations where the interaction matters more than general moderation. - **If you also take insulin or a sulfonylurea**: Alcohol suppresses the liver output of glucose, and combined with medication that lowers blood glucose it raises hypoglycaemia risk, including hours later. This combination deserves a specific conversation with your prescriber rather than general advice. - **Pancreatitis risk**: Alcohol is a leading cause of pancreatitis, which is also a recognised, if uncommon, concern with these drugs. Anyone with a history of it should treat the combination as a question for their doctor and not for the internet. - **Liver disease**: Many people prescribed these drugs have fatty liver disease. Alcohol is directly relevant there, independently of the GLP-1, and the advice comes from whoever manages it. - **Vomiting and dehydration**: Heavy drinking on top of drug-related nausea makes dehydration considerably more likely, and dehydration is the mechanism behind most serious complications people run into on these drugs. ## If you do drink 1. **Eat first.** The default is now a smaller meal than you would previously have had, which makes eating beforehand more important rather than less. 2. **Pick your day.** The days furthest from your shot are the steadiest part of the week for most people. The two days after are the roughest. See [choosing your injection day](https://penwiseapp.com/en/guides/glp-1-injection-day). 3. **Go slower than your old normal and check in.** Treat your first few occasions on treatment as new information rather than a repeat of something familiar. 4. **Water alongside.** Appetite suppression already reduces drinking of everything, so most people on these drugs start an evening less hydrated than they used to. 5. **Note what happened.** One or two entries typically tell you what your new pattern is, which is more useful than any general rule. ## The calorie question, which is the least interesting one Alcohol carries roughly seven calories per gram and is easy to drink in quantity, so it is a genuine factor in a [plateau](https://penwiseapp.com/en/guides/glp-1-weight-loss-plateau) if drinking has stayed constant while food intake has dropped by a third. For most people on these drugs, though, alcohol intake falls on its own without any deliberate effort, and it is not usually the thing standing between them and progress. If the scale has stalled and drinking has not changed, it is worth an honest look, but it is rarely the whole story. ## What to record - Occasions where you drank, and roughly how much, on the day rather than from memory a week later. - How many days after your shot it was. This is usually the variable that explains the difference between a fine evening and a bad one. - Any nausea or reflux that followed, so the pattern is visible rather than inferred. - Whether the desire to drink has changed since starting. It is the sort of shift that is obvious in six months of notes and invisible day to day. Penwise records notes and symptoms against the day and the dose, so the relationship between where you are in the week and how something went is something you can look at rather than something you have to remember. **See how the week actually affects you** Notes and symptoms logged against your dose and your injection day, all kept on your phone. Free core tracker, no account. ## Common questions **Can you drink alcohol on Ozempic or Mounjaro?** The product labels do not prohibit it, and moderation plus a few practical adjustments is the usual position. Specific caution applies if you also take insulin or a sulfonylurea, if you have a history of pancreatitis, or if you have liver disease, and those are conversations for your prescriber. **Why do I not want to drink on a GLP-1?** GLP-1 receptors are present in brain regions involved in reward and motivation, the same mechanism implicated in food noise fading. The effect is reported often enough that GLP-1 drugs are being studied specifically for alcohol use disorder, though they are not an approved treatment for it. **Does alcohol hit harder on a GLP-1?** Many people report being affected by less than before. Slowed gastric emptying changes when alcohol reaches the small intestine where it is absorbed, and a much smaller food intake and lower body mass point the same way. Treat your old tolerance as unreliable rather than assumed. **Will alcohol stop my weight loss on a GLP-1?** It carries roughly seven calories per gram and is easy to drink in quantity, so unchanged drinking alongside a much reduced food intake is a real factor in a stall. For most people on these drugs alcohol intake falls without any deliberate effort, so it is worth an honest look but is rarely the whole explanation. **Is it worse to drink right after my injection?** For most people yes. The drug level peaks in the first two to three days after a shot, which is when nausea and reflux are most likely, and alcohol irritates the stomach on top of that. The days furthest from the shot are the steadiest part of the week. **Can a GLP-1 cause low blood sugar with alcohol?** A GLP-1 on its own carries low hypoglycaemia risk. Combined with insulin or a sulfonylurea the risk is real, and alcohol adds to it by suppressing the liver output of glucose, sometimes hours later. That combination needs specific advice from your prescriber. ## Sources Every factual claim on this page traces to the product information a regulator publishes, or to a published trial. Links open on the site of whoever issued the document. - [Once-Weekly Semaglutide in Adults With Alcohol Use Disorder](https://doi.org/10.1001/jamapsychiatry.2024.4789), JAMA Psychiatry, 2025 - [Mounjaro: EPAR product information](https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro), European Medicines Agency - [Ozempic: EPAR product information](https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic), European Medicines Agency Penwise is a tracking and education tool, not a medical device. Nothing on this page is medical advice, a diagnosis or a recommendation to start, stop or change a dose. Dosing decisions belong to you and your clinician. Ozempic, Wegovy, Rybelsus, Saxenda and Victoza are trademarks of Novo Nordisk; Mounjaro, Zepbound and Trulicity are trademarks of Eli Lilly. Penwise is not affiliated with, endorsed by or connected to either company. ## Keep reading - [What food noise is, and why GLP-1 medication turns it down](https://penwiseapp.com/en/guides/what-is-food-noise): The constant background chatter about food that most people never had a word for – what it is, why it goes quiet on a GLP-1, and why it comes back late in the week. - [Nausea, constipation and sulphur burps: managing the gut effects](https://penwiseapp.com/en/guides/glp-1-nausea-and-constipation): Why these drugs upset the gut, what actually helps for each effect, the symptoms that mean call someone today, and when it is a dose question rather than a coping question. - [Choosing your injection day, and changing it safely](https://penwiseapp.com/en/guides/glp-1-injection-day): Which day you inject changes which days your side effects land on. The 72-hour rule for moving it, and why the day before your next shot is the one that feels different. - [GLP-1 medications and mood: what the reviews found](https://penwiseapp.com/en/guides/glp-1-and-mood): Regulators reviewed the suicidality signal and did not find a causal link. What that does and does not settle, and the mood changes people genuinely report.